Paralemmin (PALM) (N-Term) Peptide
PALM
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Paralemmin (PALM) products
- Paralemmin (PALM)
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LEDERRQLQH LKSKALRERW LLEGTPSSAS EGDEDLRRQM QDDEQKTRLL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PALM Antibody(ARP56270_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Paralemmin (PALM)
- Synonyms
- PALM Peptide, palm Peptide, zgc:110136 Peptide, paralemmin Peptide, paralemmin 1a Peptide, paralemmin S homeolog Peptide, PALM Peptide, palm1a Peptide, palm Peptide, palm.S Peptide, Palm Peptide
- Background
-
This gene encodes a member of the paralemmin protein family. The product of this gene is a prenylated and palmitoylated phosphoprotein that associates with the cytoplasmic face of plasma membranes and is implicated in plasma membrane dynamics in neurons and other cell types. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined.
Alias Symbols: KIAA0270
Protein Size: 343 - Molecular Weight
- 37 kDa
- Gene ID
- 5064
- NCBI Accession
- NM_001040134, NP_001035224
-
You are here:
